Steris Corp (STE) 71.00 $STE Medical Equipment Stocks

New Post Public Reply Private Reply Replies (0) Message Board

Sep 5, 2016 at 11:09 AM

Steris Corp (STE) 71.00 $STE

Medical Equipment Stocks Technical Reports -- St. Jude Medical, Wright Medical, Edwards Lifesciences, and Steris
PR Newswire - Tue Aug 23, 7:05AM CDT
This morning's stocks in focus on Stock-Callers.com belong in the Healthcare sector which rose 0.3% in midday trading on Monday, August 22, 2016. As per Forbes, the Health Care Select Sector SPDR ETF (XLV) climbed 0.2%, up 4.21% on an YTD basis. Let us now review the following Medical Appliances and Equipment equities and see how they fared at the close: St. Jude Medical Inc. (NYSE: STJ), Wright Medical Group N.V. (NASDAQ: WMGI), Edwards Lifesciences Corp. (NYSE: EW), and Steris PLC (NYSE: STE). Download the free research reports on these stocks today:
WMGI: 24.71 (+0.10), STE: 71.00 (+0.89), EW: 115.85 (-0.02), STJ: 78.65 (+0.51), WMGIZ: 1.35 (unch)

STERIS Hit by Currency Fluctuations, Customer Consolidation
Zacks Equity Research - Zacks Investment Research - Fri Aug 19, 10:27AM CDT
STERIS' (STE) first-quarter results exceeded the Zacks Consensus Estimate on bottom-line front, the top line failed to meet the same
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), STE: 71.00 (+0.89), IDXX: 114.09 (+0.93)

STERIS (STE) Beats on Q1 Earnings, Lowers FY17 Sales View
Zacks Equity Research - Zacks Investment Research - Thu Aug 11, 9:10AM CDT
STERIS' (STE) first quarter fiscal 2017 earnings surpassed the Zacks Consensus Estimate while revenues failed to meet the same.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), STE: 71.00 (+0.89), IDXX: 114.09 (+0.93)

STERIS plc Announces Financial Results for Fiscal 2017 First Quarter
Globe Newswire - Tue Aug 09, 5:00AM CDT
- First quarter revenue growth of 45% - 6% constant currency organic growth
STE: 71.00 (+0.89)

Medical Product Stocks' Earnings on Aug 9: PEN, STE & More
Zacks Equity Research - Zacks Investment Research - Mon Aug 08, 9:21AM CDT
We have already seen how the results so far have demonstrated a definite improvement from what we had experienced in the last couple of quarters.
NH: 12.52 (+0.05), STE: 71.00 (+0.89), EGRX: 60.34 (+1.32), PEN: 70.63 (+0.61), OMER: 11.10 (+0.34)

Technical Pulse on Medical Appliances & Equipment Stocks -- St. Jude Medical, ResMed, Steris, and Varian Medical Systems
PR Newswire - Mon Jun 06, 8:00AM CDT
On Friday, June 03, 2016, the NASDAQ Composite ended the trading session at 4,942.52, down 0.58%; the Dow Jones Industrial Average lost 0.18% to finish at 17,807.06; and the S&P 500 closed at 2,099.13, down 0.29%. ActiveWallSt.com has initiated coverage on the following equities: St. Jude Medical Inc. (NYSE: STJ), ResMed Inc. (NYSE: RMD), Steris PLC (NYSE: STE), and Varian Medical Systems Inc. (NYSE: VAR). Learn more about these stocks by accessing their free trade alerts at:
VAR: 96.41 (+0.52), STE: 71.00 (+0.89), RMD: 67.06 (-0.06), STJ: 78.65 (+0.51), MDSY: 1.30 (-0.08)

STERIS plc to Participate in the Jefferies Global Healthcare Conference
Globe Newswire - Wed May 25, 3:30PM CDT
About STERIS
STE: 71.00 (+0.89)

STERIS (STE): Q4 Results Strong, Currency Woes Remain
Zacks Equity Research - Zacks Investment Research - Mon May 23, 8:28AM CDT
STERIS' (STE) segmental performance buoys optimism with growth witnessed across all four segments
BSX: 24.26 (-0.07), STE: 71.00 (+0.89), BAX: 46.28 (+0.10), LMAT: 18.35 (+0.59)

STERIS (STE) Misses on Q4 Earnings, Higher Tax a Concern
Zacks Equity Research - Zacks Investment Research - Thu May 19, 5:32AM CDT
STERIS (STE) ended fiscal 2016 on a disappointing note, with its fourth-quarter results missing the Zacks Consensus Estimate on both the fronts
BSX: 24.26 (-0.07), SRDX: 29.48 (+1.24), STE: 71.00 (+0.89), BAX: 46.28 (+0.10)

Look for Shares of STERIS to Potentially Rebound after Yesterday's 3.45% Sell Off
Comtex SmarTrend(R) - Wed May 18, 2:49PM CDT
STERIS (NYSE:STE) traded in a range yesterday that spanned from a low of $64.39 to a high of $69.48. Yesterday, the shares fell 3.5%, which took the trading range below the 3-day low of $70.26 on volume of 1.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
STE: 71.00 (+0.89)

STERIS plc Announces Financial Results for Fiscal 2016 Fourth Quarter and Full Year; Provides Fiscal 2017 Outlook
Globe Newswire - Wed May 18, 5:00AM CDT
- 38% revenue growth in fourth quarter, with 5% constant currency organic growth
STE: 71.00 (+0.89)

STERIS plc to Announce Fiscal 2016 Fourth Quarter and Full Year Financial Results on May 18, 2016
Globe Newswire - Tue May 03, 3:30PM CDT
LEICESTER, U.K. - May 3, 2016- STERIS plc (NYSE: STE) ("STERIS" or the "Company"

announced today that it will host a conference call to discuss its fiscal 2016 fourth quarter and full year financial results at 10:00 a.m. Eastern Time on Wednesday, May 18, 2016. The conference call can be heard live over the Internet at www.steris-ir.com or via phone by dialing 1- 800-369-8428 in the United States and Canada, or 1-773-799-3378 internationally, then referencing the password "STERIS".
STE: 71.00 (+0.89)

STERIS Tops Q3 Earnings; Synergy Health Integration Strong
Zacks Equity Research - Zacks Investment Research - Wed Feb 10, 12:25PM CST
In the first complete quarter post the Synergy Health combination, STERIS (STE) delivered an impressive performance.
STE: 71.00 (+0.89), EW: 115.85 (-0.02), EXAC: 27.90 (+0.10), LMNX: 21.12 (+0.19)

STERIS plc Announces Fiscal 2016 Third Quarter Financial Results
Globe Newswire - Tue Feb 09, 5:01AM CST
- Revenue growth of 31%, with 7% constant currency organic growth
STE: 71.00 (+0.89)

STERIS plc to Announce Fiscal 2016 Third Quarter Financial Results on February 9, 2016
Thomson Reuters ONE - Mon Jan 25, 3:31PM CST
LEICESTER, U.K. - January 25, 2016- STERIS plc (NYSE: STE) ("STERIS" or the "Company"

announced today that it will host a conference call to discuss its third quarter fiscal 2016 financial results at 10:00 a.m. Eastern Time on Tuesday, February 9, 2016. The conference call can be heard live over the Internet at www.steris-ir.com or via phone by dialing 1- 800-369-8428 in the United States and Canada, or 1-773-799-3378 internationally, then referencing the password "STERIS".
STE: 71.00 (+0.89)

Why Steris (STE) Stock Might be a Great Pick
Zacks Equity Research - Zacks Investment Research - Wed Jan 20, 8:00AM CST
Steris is seeing solid earnings estimate revision activity and is a great company from a Zacks Industry Rank perspective
STE: 71.00 (+0.89)

STERIS (STE) Hits 52-Week High on Robust FY16 Outlook
Zacks Equity Research - Zacks Investment Research - Thu Dec 31, 12:35PM CST
STERIS' shares closed at $76.95 yesterday, translating into a decent one-year return of around 18.1%.
ETRM: 0.15 (-0.01), MASI: 59.90 (+0.47), STE: 71.00 (+0.89), EXAC: 27.90 (+0.10)

Can Varian's Expanding Product Suite Counter Forex Woes?
Zacks Equity Research - Zacks Investment Research - Wed Dec 30, 1:10PM CST
On Dec 28, we issued an updated research report on Varian Medical Systems (VAR).
MASI: 59.90 (+0.47), VAR: 96.41 (+0.52), STE: 71.00 (+0.89), EXAC: 27.90 (+0.10)

Community Health on Buying Spree Ahead of Quorum Spin-Off
Zacks Equity Research - Zacks Investment Research - Wed Dec 30, 9:20AM CST
Community Health Systems, Inc.'s (CYH) subsidiaries recently inked a definite agreement to buy majority stake in two reputed hospitals.
MASI: 59.90 (+0.47), STE: 71.00 (+0.89), CYH: 10.79 (+0.64), EXAC: 27.90 (+0.10)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Servier's Data on Tovorafenib Shows Promise in pLGG

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

JOYEE N01 Debuts Globally with First 2,000 Deliveries

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Layne's Chicken Fingers Expands with Brownsville Opening

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

KINGRVER Boosts RV Comfort with New Water Heater Lineup

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Novo's CagriSema Trials Show Promising Weight Loss

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Novo's Research Unlocks New Insights into Food Noise

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

EFICYENT Ventures to Connect at Singapore FinTech Fest

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

EZaccessMD Data Breach: Class Action Lawsuit Looms

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

WHO and RCSI Bahrain Join Forces on Health Initiatives

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...